Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | JAK2 |
Variant | R1063H |
Impact List | missense |
Protein Effect | gain of function |
Gene Variant Descriptions | JAK2 R1063H lies within the protein kinase domain 2 of the Jak2 protein (UniProt.org). R1063H results in increased Epo-induced growth, Stat5 phosphorylation and transcriptional activity, and Epo-dependent and independent hematopoietic colony formation in-vitro as compared to wild-type Jak2 in culture (PMID: 27389715). |
Associated Drug Resistance | |
Category Variants Paths |
JAK2 mutant JAK2 act mut JAK2 R1063H |
Transcript | NM_004972.4 |
gDNA | chr9:g.5126343G>A |
cDNA | c.3188G>A |
Protein | p.R1063H |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001322194.2 | chr9:g.5126343G>A | c.3188G>A | p.R1063H | RefSeq | GRCh38/hg38 |
NM_004972 | chr9:g.5126343G>A | c.3188G>A | p.R1063H | RefSeq | GRCh38/hg38 |
NM_001322195.2 | chr9:g.5126343G>A | c.3188G>A | p.R1063H | RefSeq | GRCh38/hg38 |
NM_001322195 | chr9:g.5126343G>A | c.3188G>A | p.R1063H | RefSeq | GRCh38/hg38 |
NM_001322196.1 | chr9:g.5126343G>A | c.3188G>A | p.R1063H | RefSeq | GRCh38/hg38 |
NM_001322195.1 | chr9:g.5126343G>A | c.3188G>A | p.R1063H | RefSeq | GRCh38/hg38 |
NM_004972.4 | chr9:g.5126343G>A | c.3188G>A | p.R1063H | RefSeq | GRCh38/hg38 |
NM_001322196 | chr9:g.5126343G>A | c.3188G>A | p.R1063H | RefSeq | GRCh38/hg38 |
NM_004972.3 | chr9:g.5126343G>A | c.3188G>A | p.R1063H | RefSeq | GRCh38/hg38 |
NM_001322194 | chr9:g.5126343G>A | c.3188G>A | p.R1063H | RefSeq | GRCh38/hg38 |
NM_001322196.2 | chr9:g.5126343G>A | c.3188G>A | p.R1063H | RefSeq | GRCh38/hg38 |
NM_001322194.1 | chr9:g.5126343G>A | c.3188G>A | p.R1063H | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
JAK2 mutant | childhood B-cell acute lymphoblastic leukemia | not applicable | N/A | Guideline | Prognostic | JAK2 mutations are associated with a poor prognosis in pediatric patients with B-cell acute lymphoblastic leukemia (NCCN.org). | detail... |
JAK2 mutant | B-cell acute lymphoblastic leukemia | not applicable | N/A | Guideline | Prognostic | JAK2 mutations are associated with a poor prognosis in patients with B-cell acute lymphoblastic leukemia (NCCN.org). | detail... |
JAK2 mutant | essential thrombocythemia | not applicable | N/A | Guideline | Diagnostic | JAK2 mutations aid in the diagnosis of essential thrombocythemia (NCCN.org). | detail... |
JAK2 mutant | myelofibrosis | not applicable | N/A | Guideline | Diagnostic | JAK2 mutations aid in the diagnosis of primary myelofibrosis (NCCN.org). | detail... |